Walleye Capital’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-35,083
Closed -$2.36M – 6044
2024
Q2
$2.36M Buy
35,083
+7,075
+25% +$477K ﹤0.01% 1949
2024
Q1
$1.93M Buy
+28,008
New +$1.89M ﹤0.01% 2014
2023
Q4
– Sell
-3,767
Closed -$211K – 5645
2023
Q3
$211K Sell
3,767
-32,182
-90% -$1.81M ﹤0.01% 3512
2023
Q2
$1.81M Buy
+35,949
New +$1.91M 0.01% 1400
2022
Q4
– Sell
-27,141
Closed -$1.91M – 3730
2022
Q3
$1.91M Buy
+27,141
New +$1.87M 0.04% 589

Other funds holding AXNX

Walleye Capital's AXNX Position: Q3 2024 in Review

Walleye Capital sold out of Axonics, Inc. Common Stock (AXNX) in Q3 2024, closing a stake of 35,083 shares — an estimated $2.36M sold.

Walleye Capital first reported a position in AXNX in Q3 2022 and held it in 5 quarters. The position peaked at $2.36M in Q2 2024. 233 funds tracked by Wall St. Rank hold AXNX as of Q3 2024.

  • Walleye Capital reported no remaining Axonics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Walleye Capital sold 35,083 Axonics, Inc. Common Stock shares in Q3 2024, an estimated $2.36M.
  • Walleye Capital first reported a position in Axonics, Inc. Common Stock in Q3 2022 and held it in 5 quarters.
  • Walleye Capital's Axonics, Inc. Common Stock position peaked at $2.36M in Q2 2024.
  • 233 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2024.

Based on Walleye Capital's 13F filing for Q3 2024, filed 14 Nov 2024.